ACE and hydrops fetalis: Women with HF were also less likely than men with HF to be receiving β-blockers (81.9% vs 92.0%; P < .001) or angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (82.5% vs 92.6%; P < .001) (Table 2).